Lessons learned from developing potency assays to detect activity and variation for cell- and receptor-mediated products — beyond the comforts of a well-heeled company.
- A Flexible Mindset For Bridging Between Cell-Based Assay Groups
- Advanced Manufacturing And CDMOs Are Rewriting The CGT Cost Equation
- Exploring Outsourcing's Role In CGT Scalability And Affordability
- Redefining CGT With Exosomes And EVs
- 4 Centralized Comparator Sourcing Models To Fortify Supply Chains
- Essential Steps For A Successful Analytical Tech Transfer
- From Discovery To Delivery: Accelerating The Path Forward For Gene Therapies
- Preparing For FDA's Expanded Use Of Unannounced Inspections At Foreign Manufacturing Facilities
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Ergonomics And Cleaning Ease Reduce Repetitive Stress Injuries And Contamination In Pharmaceutical Lab Workflows
The repetitive nature of routine laboratory procedures can put technicians and scientists at risk for repetitive strain injury. Routine activities often include reoccurrence of the same movements over and over, which can take a toll on hands, wrists and shoulders and ultimately can lead to serious damage. Choosing the right tools can make all the difference.
-
Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024)
CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.
-
Functional Characterization Of 3D Assembled Neurospheres
Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.
-
High-Throughput 90-Minute ELISA
Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.
-
Innovative Therapeutic Applications Of Ion Exchange Resins
Chromatography resins are aiding in the delivery of cancer and inflammatory disease therapies. Learn how ion exchange resins act as therapeutic carriers for advanced drug delivery.
-
What Clinical Trial Decision Makers Are Prioritizing In 2025
In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
-
Lentiviral Vector Production Using Single-Use Bioreactors
Here, we outline a scalable and robust upstream process developed for LVV production of HEK293T cells and demonstrate how to expand HEK293T suspension cells.
-
Improved T Cell Expansion Using Closed, Automated Stirred-Tank Bioreactors
A shift from traditional rocking motion systems to stirred-tank bioreactors can enhance T cell expansion, offering greater scalability and more intimate process control.
-
Fully Automated Cell Culture Passaging And Expansion
Automating cell culture tasks can reduce human error and free scientists from labor-intensive routines. Discover how imaging and automated systems enhance accuracy and reproducibility in cell culture processes.
-
Pre-Launch Checklist - A Roadmap To Success
The path from groundbreaking therapy to readily available treatment requires a strategic approach. Delve into ten critical questions that can help you chart a successful course for your CGT therapy.
NEWSLETTER ARCHIVE
- 07.18.25 -- Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis
- 07.17.25 -- Techniques To Streamline Development From Feasibility To Launch
- 07.17.25 -- Navigating Allogeneic Cell Therapy Supply Chain Management
- 07.16.25 -- Fix Your CGT Launch Plan: Speed Isn't The Problem. Strategy Is.
- 07.16.25 -- Inside AviadoBio And Astellas's Shared Mission To Bring Gene Therapy To Patients With FTD-GRN

- Redefining CGT With Exosomes And EVs
- Inside AviadoBio And Astellas's Shared Mission To Bring Gene Therapy To Patients With FTD-GRN
- Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More
- Rethinking Academic Translation In CGT: Inside The RISE Framework At Mass General Brigham
- The Promise Of Focused Ultrasound For AAV Gene Therapy Delivery
CELL AND GENE CONTENT COLLECTIONS

While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections